Some Medications Considered Safe for Use During Pregnancy

Some Medications Considered Safe for Use During Pregnancy
Condition	Medication
Asthma	Budesonide inhaled or nasal spray (Pulmicort®, Rhinocort ®)
Bladder infection (UTI)	Nitrofurantoin (Macrobid®)
	- Avoid in patients with possible G6PD deficiency
Cough	Dextromethrophan  (Robitussin DM sugar free ®)
Constipation	Metamucil® , Citrucel®,
	Docusate
	Milk of magnesia.
	Polyethyelene glycol (Miralax®)
Diabetes	Insulin
	Glyburide (Micronase®)
	Metformin (Glucophage®)
Diarrhea	Loperamide (Imodium A-D ®)
Gas	Simethicone
Gastroesophageal reflux disease (GERD),	Ranitidine (Zantac®)
Hayfever, sneezing, runny nose, itchy watery eyes	Chlorpheniramine
	Diphenhydramine                              Clemastine (Tavegyl®)
Headache or fever:	Acetaminophen (APAP,Paracetamol,Panadol, Tylenol®)
Hemorrhoids	Preparation H®
	Anusol
High blood pressure	Methyldopa (Aldomet®)
Hyperprolactinemia	Bromocriptine (Parlodel®)
	Carbergoline (Dostinex®)
Hypothyroidism	Thyroid hormone
	Levothyroxine
Infection	Acyclovir (Zovirax ®)
	Azthitromycin (Zithromax ®)
	Cepaholosporins
	examples: Cephalexin (Keflex®),
	Cefazolin (Ancef ®), cefaclor (Ceclor®)
	Clindamycin (Cleocin®)
	Erythromycin
	Penicillins
	example Amoxicillin (Amoxil®),
	Amoxicillin Clavulanate (Augmentin®),   Amoxicillin-clavulanate has been assigned to pregnancy category B by the FDA Amoxicillin-clavulanate should only be given during pregnancy when need has been clearly established.
	methicillin, carbenicillin
	Metronidazole (Flagyl®)
Insomnia	Doxylamine
Motion sickness	Dimenhydrinate (Dramamine ®)
Nasal congestion	Pseudoephedrine
	-Avoid in first trimester.
Nasal congestion, sneezing, runny nose, itchy watery eyes	Actifed Cold and Allergy ®
	Ingredients: Triprolidine, Pseudoephedrine
	-Avoid in first trimester.
Nasal congestion, sneezing, runny nose, itchy watery eyes, fever, and headache	Actifed Cold and Sinus ®
	Ingredients: Acetaminophen, Chlorpheniramine,
	Pseudoephedrine- Avoid in first trimester.
Nausea	Ginger
	Pyridoxine 25 mg PO TID WITH
	Unisom Sleep Tabs (Doxylamine Succinate 25 mg) 1/2 tablet TID
	Metoclopramide
Preeclampsia	Magnesium sulfate
Vaginal yeast infection	Clotrimazole cream

Recently approved drugs by FDA

AXIRON (testosterone) Topical Solution

Company: Eli Lilly and Company

Date of Approval: November 23, 2010

Treatment for: Hypogonadism -- Male

Axiron (testosterone) is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

Gablofen (baclofen) Injection

Company: CNS Therapeutics

Date of Approval: November 19, 2010

Treatment for: Cerebral Spasticity, Chronic Spasticity

Gablofen (baclofen) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity.

XGEVA (denosumab) Injection

Company: Amgen Inc.

Date of Approval: November 18, 2010

Treatment for: Osteolytic Bone Metastases of Solid Tumors

Xgeva (denosumab) is a RANK ligand (RANKL) inhibitor indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors.

HALAVEN (eribulin mesylate) Injection - formerly E7389

Company: Eisai Co., Ltd.

Date of Approval: November 15, 2010

Treatment for: Breast Cancer

Halaven (eribulin mesylate) is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer.

EGRIFTA (tesamorelin) Injection

Company: Theratechnologies

Date of Approval: November 10, 2010

Treatment for: Reduction of Excess Abdominal Fat in HIV-Infected Patients with Lipodystrophy

Egrifta (tesamorelin) is a synthetic analogue of growth hormone releasing factor (GRF) for the treatment of excess abdominal fat in HIV patients with lipodystrophy.

KOMBIGLYZE XR (saxagliptin and metformin) Extended-Release Tablets

Company: Bristol-Myers Squibb Company and AstraZeneca

Date of Approval: November 5, 2010

Treatment for: Diabetes Mellitus Type II

Kombiglyze XR (saxagliptin and metformin) is a once-daily fixed dose combination of the dipeptidyl peptidase-4 (DPP-4) inhibitor Onglyza (saxagliptin) and extended release metformin for the treatment of type 2 diabetes.

OFIRMEV (acetaminophen) Intravenous Injection - formerly Acetavance

Company: Cadence Pharmaceuticals, Inc.

Date of Approval: November 2, 2010

Treatment for: Fever, Pain

Ofirmev (acetaminophen) is an intravenous analgesic product for the treatment of acute pain and fever in adults and children.